Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Very low pandemic influenza A (H1N1) 2009 mortality associated with early neuraminidase inhibitor treatment in Japan: analysis of 1000 hospitalized children.

Sugaya N, Shinjoh M, Mitamura K, Takahashi T.

J Infect. 2011 Oct;63(4):288-94. doi: 10.1016/j.jinf.2011.06.008. Epub 2011 Jun 22.

PMID:
21722665
2.

Widespread use of neuraminidase inhibitors in Japan.

Sugaya N.

J Infect Chemother. 2011 Oct;17(5):595-601. doi: 10.1007/s10156-011-0288-0. Epub 2011 Aug 18. Review.

PMID:
21850418
3.

Supply of neuraminidase inhibitors related to reduced influenza A (H1N1) mortality during the 2009-2010 H1N1 pandemic: summary of an ecological study.

Miller PE, Rambachan A, Hubbard RJ, Li J, Meyer AE, Stephens P, Mounts AW, Rolfes MA, Penn CR.

Influenza Other Respir Viruses. 2013 Sep;7 Suppl 2:82-6. doi: 10.1111/irv.12092. Review.

4.

The use of antiviral agents for the management of severe influenza.

Smith JR, Ariano RE, Toovey S.

Crit Care Med. 2010 Apr;38(4 Suppl):e43-51. doi: 10.1097/CCM.0b013e3181c85229. Review.

PMID:
19935416
5.

[Role of neuraminidase inhibitors for the treatment of influenza A virus infections].

Ferraris O, Escuret V, Bouscambert-Duchamp M, Lina B, Morfin F.

Pathol Biol (Paris). 2010 Apr;58(2):e69-78. doi: 10.1016/j.patbio.2010.01.011. Epub 2010 Mar 19. Review. French.

PMID:
20303677
6.

[Drug-resistant influenza viruses: an overview].

Hatakeyama S.

Nihon Rinsho. 2010 Sep;68(9):1671-8. Review. Japanese.

PMID:
20845746
7.

Oseltamivir in neonates, infants and young children: a focus on clinical pharmacology.

Karadag-Oncel E, Ceyhan M.

Infect Disord Drug Targets. 2013 Feb;13(1):15-24. Review.

PMID:
23675923
8.

Early versus late oseltamivir treatment in severely ill patients with 2009 pandemic influenza A (H1N1): speed is life.

Kumar A.

J Antimicrob Chemother. 2011 May;66(5):959-63. doi: 10.1093/jac/dkr090. Epub 2011 Mar 15. Review.

PMID:
21406435
9.

Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.

Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Al Khuwaitir TS, Al Mamun A, Anovadiya AP, Azziz-Baumgartner E, Báez C, Bassetti M, Beovic B, Bertisch B, Bonmarin I, Booy R, Borja-Aburto VH, Burgmann H, Cao B, Carratala J, Denholm JT, Dominguez SR, Duarte PA, Dubnov-Raz G, Echavarria M, Fanella S, Gao Z, Gérardin P, Giannella M, Gubbels S, Herberg J, Iglesias AL, Hoger PH, Hu X, Islam QT, Jiménez MF, Kandeel A, Keijzers G, Khalili H, Knight M, Kudo K, Kusznierz G, Kuzman I, Kwan AM, Amine IL, Langenegger E, Lankarani KB, Leo YS, Linko R, Liu P, Madanat F, Mayo-Montero E, McGeer A, Memish Z, Metan G, Mickiene A, Mikić D, Mohn KG, Moradi A, Nymadawa P, Oliva ME, Ozkan M, Parekh D, Paul M, Polack FP, Rath BA, Rodríguez AH, Sarrouf EB, Seale AC, Sertogullarindan B, Siqueira MM, Skręt-Magierło J, Stephan F, Talarek E, Tang JW, To KK, Torres A, Törün SH, Tran D, Uyeki TM, Van Zwol A, Vaudry W, Vidmar T, Yokota RT, Zarogoulidis P; PRIDE Consortium Investigators, Nguyen-Van-Tam JS.

Lancet Respir Med. 2014 May;2(5):395-404. doi: 10.1016/S2213-2600(14)70041-4. Epub 2014 Mar 19. Review.

PMID:
24815805
10.

Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009-2010 influenza A(H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients.

Muthuri SG, Myles PR, Venkatesan S, Leonardi-Bee J, Nguyen-Van-Tam JS.

J Infect Dis. 2013 Feb 15;207(4):553-63. doi: 10.1093/infdis/jis726. Epub 2012 Nov 29. Review.

11.

Peramivir: an intravenous neuraminidase inhibitor for the treatment of 2009 H1N1 influenza.

Mancuso CE, Gabay MP, Steinke LM, Vanosdol SJ.

Ann Pharmacother. 2010 Jul-Aug;44(7-8):1240-9. doi: 10.1345/aph.1P031. Epub 2010 Jun 1. Review.

PMID:
20516360
12.

Review of the pandemic (H1N1) 2009 among pregnant Japanese women.

Nakai A, Saito S, Unno N, Kubo T, Minakami H.

J Obstet Gynaecol Res. 2012 May;38(5):757-62. doi: 10.1111/j.1447-0756.2011.01812.x. Epub 2012 Apr 9. Review.

PMID:
22487092
13.

Pharmacokinetics and pharmacodynamics of oseltamivir in neonates, infants and children.

Standing JF, Tsolia M, Lutsar I.

Infect Disord Drug Targets. 2013 Feb;13(1):6-14. Review.

PMID:
23675922
14.

Antiviral treatment of influenza in children.

Garg S, Fry AM, Patton M, Fiore AE, Finelli L.

Pediatr Infect Dis J. 2012 Feb;31(2):e43-51. doi: 10.1097/INF.0b013e31824671ab. Review.

PMID:
22252215
15.

Neurological complications of pandemic influenza A H1N1 2009 infection: European case series and review.

Surana P, Tang S, McDougall M, Tong CY, Menson E, Lim M.

Eur J Pediatr. 2011 Aug;170(8):1007-15. doi: 10.1007/s00431-010-1392-3. Epub 2011 Jan 14. Review.

PMID:
21234600
16.

Treating influenza with statins and other immunomodulatory agents.

Fedson DS.

Antiviral Res. 2013 Sep;99(3):417-35. doi: 10.1016/j.antiviral.2013.06.018. Epub 2013 Jul 4. Review.

PMID:
23831494
17.

Diagnosis, management and outcomes of adults hospitalized with influenza.

Lee N, Ison MG.

Antivir Ther. 2012;17(1 Pt B):143-57. doi: 10.3851/IMP2059. Epub 2012 Feb 3. Review.

PMID:
22311561
18.

In brief: concerns about oseltamivir (Tamiflu).

[No authors listed]

Med Lett Drugs Ther. 2015 Jan 19;57(1460):14. Epub 2015 Jan 19. Review. No abstract available.

PMID:
25536909

Supplemental Content

Support Center